Carcinoid Tumors of the Orbit and Ocular Adnexa.
Journal
Ophthalmic plastic and reconstructive surgery
ISSN: 1537-2677
Titre abrégé: Ophthalmic Plast Reconstr Surg
Pays: United States
ID NLM: 8508431
Informations de publication
Date de publication:
Historique:
pubmed:
5
6
2020
medline:
25
5
2021
entrez:
5
6
2020
Statut:
ppublish
Résumé
Well-differentiated neuroendocrine or carcinoid tumors are found most commonly in the gastrointestinal tract. When metastatic to the orbit, they tend to have a propensity for the extraocular muscles. The purpose of this study was to better understand the diversity in presentation of orbital carcinoid disease and to determine predictors for survival. In this observational cross-sectional cohort study, data from 8 tertiary orbital practices were compiled. Demographic, clinical, pathologic, American Joint Committee on Cancer stage and grade, imaging, and management data were extracted for all the patients. Descriptive statistics were calculated. Subgroups were compared utilizing analysis of variance analyses and Kaplan-Meier curves. Time to progression and disease-specific and overall mortality were calculated. Comparisons were performed for the following a priori pairs: unknown versus known primary tumor, single versus multiple extraocular muscle involvement, unilateral versus bilateral orbital disease, extraocular muscle versus other orbital involvement, and excisional versus incisional surgery. A total of 28 patients with carcinoid tumors of the orbit were identified. Of these, 57.1% of patients were female, the mean age at diagnosis of the primary tumor was 58.8 years and the mean age at diagnosis of orbital disease was 62.6 years. At primary presentation, all patients were American Joint Committee on Cancer stage III or IV and 21.4% demonstrated carcinoid syndrome. Muscle involvement was noted in 78.6% of patients, and of these, 72% were noted to have single muscle disease. Eight patients had no primary tumor identified; 3 of these 8 demonstrated disseminated disease at the time of diagnosis. The overall 5-year survival rate was 81.8% from diagnosis of primary tumor and 50% from diagnosis of orbital disease. Subgroup analysis revealed that patients with unilateral orbital disease when compared with bilateral orbital disease had a longer progression-free survival and time to death from all causes (p = 0.025). Patients with disease localized to the orbit at presentation had longer time to death than those with disseminated disease. Treatment with surgery, radiation, or octreotide did not appear to affect survival. Patients managed with systemic chemotherapy had a shorter time of survival than the rest of the group. All other subgroup comparisons were not found to be statistically significant. Neuroendocrine tumors of the orbit represent a wide spectrum of disease, with some cases being part of disseminated disease, while others being localized presentations. This heterogeneity may be responsible for the slightly higher overall survival in these patients than others with metastatic carcinoid tumors in other locations.
Identifiants
pubmed: 32496392
pii: 00002341-202105000-00003
doi: 10.1097/IOP.0000000000001715
doi:
Substances chimiques
Octreotide
RWM8CCW8GP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
217-225Informations de copyright
Copyright © 2021 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.
Déclaration de conflit d'intérêts
The authors have conflicts of interest to disclose.
Références
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–959.
Goldberg RA, Rootman J, Cline RA. Tumors metastatic to the orbit: a changing picture. Surv Ophthalmol. 1990;35:1–24.
Mehta JS, Abou-Rayyah Y, Rose GE. Orbital carcinoid metastases. Ophthalmology. 2006;113:466–472.
Gupta A, Chazen JL, Phillips CD. Carcinoid tumor metastases to the extraocular muscles: MR imaging and CT findings and review of the literature. AJNR Am J Neuroradiol. 2011;32:1208–1211.
Matsuo T, Ichimura K, Tanaka T, et al. Neuroendocrine tumor (carcinoid) metastatic to orbital extraocular muscle: case report and literature review. Strabismus. 2010;18:123–128.
Nicolò M, Piccolino FC, Ghiglione D, et al. Multiple bilateral choroidal metastatic tumors from a small-cell neuroendocrine carcinoma of unknown primary site. Eur J Ophthalmol. 2005;15:148–152.
Sivagnanavel V, Riordan-Eva P, Jarosz J, et al. Bilateral orbital metastases from a neuroendocrine tumor. J Neuroophthalmol. 2004;24:240–242.
Isidori AM, Kaltsas G, Frajese V, et al. Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide. J Clin Endocrinol Metab. 2002;87:1627–1633.
Knox RJ, Gigantelli JW, Arthurs BP. Recurrent orbital inflammation from metastatic orbital carcinoid tumor. Ophthalmic Plast Reconstr Surg. 2001;17:137–139.
Fan JT, Buettner H, Bartley GB, et al. Clinical features and treatment of seven patients with carcinoid tumor metastatic to the eye and orbit. Am J Ophthalmol. 1995;119:211–218.
Shetlar DJ, Font RL, Ordóñez N, et al. A clinicopathologic study of three carcinoid tumors metastatic to the orbit. Immunohistochemical, ultrastructural, and DNA flow cytometric studies. Ophthalmology. 1990;97:257–264.
Riddle PJ, Font RL, Zimmerman LE. Carcinoid tumors of the eye and orbit: a clinicopathologic study of 15 cases, with histochemical and electron microscopic observations. Hum Pathol. 1982;13:459–469.
Honrubia FM, Davis WH, Moore MK, et al. Carcinoid syndrome with bilateral orbital metastases. Am J Ophthalmol. 1971;72:1118–1121.
Zimmerman LE, Stangl R, Riddle PJ. Primary carcinoid tumor of the orbit. A clinicopathologic study with histochemical and electron microscopic observations. Arch Ophthalmol. 1983;101:1395–1398.
Font RL, Ferry AP. Carcinoma metastatic to the eye and orbit III. A clinicopathologic study of 28 cases metastatic to the orbit. Cancer. 1976;38:1326–1335.
Eftekhari K, McClelland CM, Gausas RE, et al. A case of extraocular muscle enlargement causing diplopia: thinking beyond thyroid eye disease. J Neuroophthalmol. 2013;33:179–182.
Kim HJ, Shinder R, Mirani N, et al. Carcinoid tumor metastatic to the tarsal conjunctivae. Ophthalmic Plast Reconstr Surg. 2011;27:e6–e8.
Turaka K, Mashayekhi A, Shields CL, et al. A case series of neuroendocrine (carcinoid) tumor metastasis to the orbit. Oman J Ophthalmol. 2011;4:125–128.
Sira M, Clauss RP, Maclean C, et al. Orbital metastases from neuroendocrine carcinoma, masquerading as graves orbitopathy. Orbit. 2010;29:94–96.
Bohman E, Sahlin S, Seregard S. Carcinoid presenting as extrinsic eye muscle metastasis. Acta Ophthalmol. 2009;87:916–917.
Kiratli H, Yilmaz PT, Yildiz ZI. Metastatic atypical carcinoid tumor of the inferior rectus muscle. Ophthalmic Plast Reconstr Surg. 2008;24:482–484.
Gerencer RZ, Patel U, Hunter C, et al. The role of endoscopic sinus surgery in the diagnosis and treatment of metastatic orbital carcinoid tumors. Ear Nose Throat J. 2007;86:157–161.
Borota OC, Kloster R, Lindal S. Carcinoid tumour metastatic to the orbit with infiltration to the extraocular orbital muscle. APMIS. 2005;113:135–139.
Khaw P, Ball D, Duchesne G. Carcinoid tumour of the orbital muscles: a rare occurrence. Australas Radiol. 2001;45:179–181.
Smith JM, Rose GE, Plowman PN. Pulsatile visual phenomenon, ipsilateral to a metastatic orbital carcinoid, occurring during usage of sildenafil (Viagra). Eye (Lond). 2001;15pt 6809–811.
Couch DA, O’Halloran HS, Hainsworth KM, et al. Carcinoid metastasis to extraocular muscles: case reports and review of the literature. Orbit. 2000;19:263–269.
Tunc M, Wendel R, Char DH. Bilateral multifocal choroidal carcinoid: long-term follow-up without treatment. Am J Ophthalmol. 1998;125:875–876.
Perri P, Bandello F, Police G, et al. Multiple bilateral choroidal metastatic tumor from bronchial carcinoid: case report. Retina. 1998;18:385–386.
Hanson MW, Schneider AM, Enterline DS, et al. Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit. J Nucl Med. 1998;39:647–650.
Shields CL, Shields JA, Gross NE, et al. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104:1265–1276.
El-Toukhy E, Levine MR, Abdul-Karim FW, et al. Carcinoid tumors of the orbit: a dilemma of diagnosis and treatment. Ophthalmic Plast Reconstr Surg. 1996;12:279–283.
Aburn NS, Whitehead K, Sullivan TJ. Bronchopulmonary atypical carcinoid tumour metastatic to the orbit. Aust N Z J Ophthalmol. 1995;23:241–244.
Harbour JW, De Potter P, Shields CL, et al. Uveal metastasis from carcinoid tumor. Clinical observations in nine cases. Ophthalmology. 1994;101:1084–1090.
Nida TY, Hall WA, Glantz MJ, et al. Metastatic carcinoid tumor to the orbit and brain. Neurosurgery. 1992;31:949–952; discussion 952.
Harris GJ, Urdaneta LF, Mitros FA. Gastrointestinal carcinoid tumor metastatic to the orbit. South Med J. 1989;82:1549–1552.
Braffman BH, Bilaniuk LT, Eagle RC Jr, et al. MR imaging of a carcinoid tumor metastatic to the orbit. J Comput Assist Tomogr. 1987;11:891–894.
Shields CL, Shields JA, Eagle RC Jr, et al. Orbital metastasis from a carcinoid tumor. Computed tomography, magnetic resonance imaging, and electron microscopic findings. Arch Ophthalmol. 1987;105:968–971.
Divine RD, Anderson RL, Ossoinig KC. Metastatic carcinoid unresponsive to radiation therapy presenting as a lacrimal fossa mass. Ophthalmology. 1982;89:516–520.
Krohel GB, Perry S, Hepler RS. Acute hypertension with orbital carcinoid tumor. Arch Ophthalmol. 1982;100:106–108.
Rush JA, Waller RR, Campbell RJ. Orbital carcinoid tumor metastatic from the colon. Am J Ophthalmol. 1980;89:636–640.
Fishman ML, Rosenthal S. Optic nerve metastasis from a mediastinal carcinoid tumour. Br J Ophthalmol. 1976;60:583–588.
Fu YS, McWilliams NB, Stratford TP, et al. Bronchial carcinoid with choroidal metastasis in an adolescent. Case report and ultrastructural study. Cancer. 1974;33:707–715.
Ricketts MM, Price T, Thomas M. Choroidal metastasis of bronchial adenoma; adenoid-cystic carcinoma type. Am J Ophthalmol. 1955;39:33–36.
Coupland SE, Krause L, Delecluse HJ, Anagnostopoulos I, Foss HD, Hummel M, et al. Lymphoproliferative lesions of the ocular adnexa - analysis of 112 cases. Ophthalmology. 1998;105:1430–1441.
Demirci H, Shields CL, Karatza EC, Shields JA. Orbital lymphoproliferative tumors: Analysis of clinical features and systemic involvement in 160 cases. Ophthalmology. 2008;115:1626–1631.
Jenkins C, Rose GE, Bunce C, Cree I, Norton A, Plowman PN, et al. Clinical features associated with survival of patients with lymphoma of the ocular adnexa. Eye. 2003;14:802–820.
Rootman DB, Mavrikakis I, Connors JM, Rootman J. Primary, unilateral ocular adnexal lymphoma: Disease progression and long-term survival. Ophthalmic Plast Reconstr Surg. 2011;27:405–409.